Darrin Disley

R&D

In the latest episode of the podcast pharmaphorum’s website editor Catherine Longworth speaks with Dr Darrin Disley, who's the CEO of Mogrify.

News

Armed with new phase 3 data, Bayer is preparing to file a PET imaging agent that could accelerate the diagnosis of cardiac amyloidosis.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.